Aberdeen Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-438
| Closed | -$255K | – | 177 |
|
|
2024
Q1 | $255K | Hold |
438
| – | – | 0.15% | 135 |
|
|
2023
Q4 | $232K | Hold |
438
| – | – | 0.17% | 135 |
|
|
2023
Q3 | $222K | Hold |
438
| – | – | 0.17% | 134 |
|
|
2023
Q2 | $229K | Buy |
438
+35
| +9% | +$18.3K | 0.17% | 132 |
|
|
2023
Q1 | $232K | Hold |
403
| – | – | 0.17% | 134 |
|
|
2022
Q4 | $222K | Hold |
403
| – | – | 0.17% | 138 |
|
|
2022
Q3 | $204K | Hold |
403
| – | – | 0.18% | 133 |
|
|
2022
Q2 | $219K | Hold |
403
| – | – | 0.17% | 135 |
|
|
2022
Q1 | $238K | Hold |
403
| – | – | 0.16% | 136 |
|
|
2021
Q4 | $269K | Buy |
403
+30
| +8% | +$20K | 0.18% | 122 |
|
|
2021
Q3 | $213K | Sell |
373
-27
| -7% | -$15.4K | 0.21% | 119 |
|
|
2021
Q2 | $202K | Buy |
+400
| New | +$202K | 0.19% | 126 |
|
|
2021
Q1 | – | Sell |
-528
| Closed | -$246K | – | 154 |
|
|
2020
Q4 | $246K | Buy |
+528
| New | +$246K | 0.19% | 122 |
|
|
2020
Q3 | – | Sell |
-578
| Closed | -$209K | – | 147 |
|
|
2020
Q2 | $209K | Buy |
+578
| New | +$209K | 0.22% | 119 |
|